全文获取类型
收费全文 | 1011篇 |
免费 | 219篇 |
国内免费 | 106篇 |
专业分类
耳鼻咽喉 | 13篇 |
儿科学 | 32篇 |
妇产科学 | 13篇 |
基础医学 | 184篇 |
口腔科学 | 37篇 |
临床医学 | 182篇 |
内科学 | 285篇 |
皮肤病学 | 11篇 |
神经病学 | 21篇 |
特种医学 | 83篇 |
外科学 | 93篇 |
综合类 | 46篇 |
预防医学 | 49篇 |
眼科学 | 8篇 |
药学 | 72篇 |
中国医学 | 1篇 |
肿瘤学 | 206篇 |
出版年
2019年 | 9篇 |
2018年 | 13篇 |
2017年 | 13篇 |
2016年 | 18篇 |
2015年 | 22篇 |
2014年 | 16篇 |
2013年 | 32篇 |
2012年 | 29篇 |
2011年 | 31篇 |
2010年 | 30篇 |
2009年 | 28篇 |
2008年 | 33篇 |
2007年 | 84篇 |
2006年 | 41篇 |
2005年 | 52篇 |
2004年 | 34篇 |
2003年 | 39篇 |
2002年 | 33篇 |
2001年 | 27篇 |
2000年 | 45篇 |
1999年 | 18篇 |
1998年 | 56篇 |
1997年 | 44篇 |
1996年 | 45篇 |
1995年 | 23篇 |
1994年 | 36篇 |
1993年 | 17篇 |
1992年 | 20篇 |
1991年 | 17篇 |
1990年 | 24篇 |
1989年 | 36篇 |
1988年 | 31篇 |
1987年 | 35篇 |
1986年 | 36篇 |
1985年 | 38篇 |
1984年 | 16篇 |
1983年 | 14篇 |
1982年 | 14篇 |
1981年 | 17篇 |
1980年 | 11篇 |
1979年 | 17篇 |
1978年 | 14篇 |
1977年 | 12篇 |
1976年 | 12篇 |
1975年 | 9篇 |
1971年 | 12篇 |
1970年 | 9篇 |
1969年 | 8篇 |
1968年 | 14篇 |
1967年 | 8篇 |
排序方式: 共有1336条查询结果,搜索用时 15 毫秒
1.
CM Reid M. Nelson P. Beckinsale P. Ryan LMH Wing LJ Beilin MA Brown GLR Jennings CI Johnston J. Marley JJ McNeil TO Morgan J. Shaw ID Steven MJ West 《Clinical and experimental pharmacology & physiology》1997,24(5):370-373
1. The present study aimed to determine the feasibility of conducting a 5 year cardiovascular outcome trial of the treatment of 6000 elderly hypertensive patients in Australian general practices. 2. General practitioners (GPs) were invited to participate by mail and personal follow-up. Patient records were reviewed to identify subjects for a blood pressure (BP) screening programme. Blood pressure was measured on three occasions and eligible subjects were included if the average BP was 160 mmHg systolic or 90 mmHg diastolic if systolic BP was 140 mmHg. 3. Seven hundred and forty-one GPs were approached and 89 were enrolled in the study (12% of mail invites and 75% of those receiving a personal contact). In 16 practices where screening was completed, 82 000 records were reviewed to identify 4% patients eligible for screening. Twenty-two per cent of eligible subjects attended screening. Of 1938 subjects screened, 180 (9%) had BP 5=160/90 mmHg. Forty-seven percent of subjects (n = 916) were receiving antihypertensive therapy and 184 (20%) were withdrawn from therapy. One hundred and sixteen (63%) of these subjects had BP return to study entry levels within 6 weeks. Fifty-seven newly diagnosed and 81 previously treated subjects were randomized (7% of the screened population). 4. Based on the high participation rate of GPs, the response rate of patients to attend a BP screening programme and the 7% randomization to screening ratio for entry into the study, the ANBP2 pilot study has demonstrated that it is feasible to recruit subjects from Australian general practices to a cardiovascular outcome trial. 相似文献
2.
3.
Among the 81 cultures of Salmonella typhimurium of phage type 141 examined, 72 had been isolated from Sheffield incidents in 1984-5 and 9 were Scottish isolates from 1986-7. All of these cultures from diverse sources belonged to primary biotype 31; 79 were of full biotype 31beg and 2 anaerogenic cultures were of full biotype 31begj. This is the first known occasion on which an epidemic strain of S. typhimurium of phage type/biotype 141/31beg has been implicated in outbreaks of human or animal infection in the UK. Because previous epidemic strains of S. typhimurium of phage type 141 in the UK belonged to biotypes 1f and 9f which are phylogenetically unrelated to biotype 31beg, the likely origin of this most recent epidemic S. typhimurium strain of phage type/biotype 141/31beg is discussed. 相似文献
4.
5.
M Petrou M Brugiatelli J Old P Hurley R H Ward K P Wong C Rodeck B Modell 《British journal of obstetrics and gynaecology》1992,99(12):985-989
OBJECTIVE: Alpha zero (alpha 0 or alpha-1) thalassaemia is an important genetic risk for women originating from Hong Kong, Singapore, Vietnam, Thailand, the Philippines or South China. Cypriots are also at risk. Carriers of alpha zero thalassaemia trait can be detected by routine haemoglobinopathy screening. When a couple are both carriers, in each pregnancy there is a 25% risk that the fetus will have alpha thalassaemia hydrops fetalis; this is fatal for the fetus and carries serious obstetric and psychological risks for the mother. Most informed couples at risk request prenatal diagnosis and selective abortion. This study investigates the effectiveness of screening, counselling and prenatal diagnosis for alpha thalassaemia hydrops fetalis in the UK. DESIGN: Retrospective analysis of the notes. SUBJECTS: 18 couples attending University College Hospital London for prenatal diagnosis of alpha thalassaemia hydrops fetalis since 1982. RESULTS: The study shows underdiagnosis of both alpha zero thalassaemia trait and alpha thalassaemia hydrops fetalis leading to avoidable stillbirths and complications in pregnancy. CONCLUSION: We recommend early screening for alpha zero thalassaemia trait for all women of Southeast Asian or eastern Mediterranean origin and the offer of prenatal diagnosis when indicated. The diagnosis of alpha thalassaemia hydrops fetalis should be considered in women of the relevant ethnic origin who have a stillbirth, neonatal death, abnormal ultrasound findings at fetal anomaly scanning (especially a large placenta), or who develop pre-eclampsia. 相似文献
6.
BACKGROUND: The recent introduction of urea sensors for dialysis monitoring
has made possible new approaches to urea kinetic modelling. In this study
we show how the equilibrated postdialysis urea concentration (Ceq) and Kt/V
corrected for double-pool urea kinetics (Kt/Vdp) can be accurately
determined using an on-line sensor providing a continuous measure of blood
water urea. A modification of the Smye constant volume double-pool theory
led to the following equations for Ceq and Kt/Vdp [formula: see text] where
Cpre is the blood concentration measured at the start of dialysis, t is the
length of the dialysis session (in min) and S(ex) is the constant slope of
the blood urea logarithm concentration decline following development of the
intercompartmental urea concentration gradient in the first 30-60 min of
dialysis. METHODS: These equations were tested in 11 patients undergoing
165-240 min of paired filtration dialysis with continuous monitoring of
blood urea concentration. Cpre was determined as the plateau concentration
during a preliminary period of 15-20 min of slow isolated ultrafiltration.
S(ex) was accurately determined from linear regression applied to the urea
sensor data from the 80-min point to the end of dialysis. RESULTS: Ceq and
Kt/Vdp determined from the above equations compared closely to values
determined from 25-40 min of urea rebound monitoring with the urea sensor:
10.6 +/- 3.0 versus 10.8 +/- 2.7 mmol/l (mean +/- SD) for Ceq and 1.21 +/-
0.24 versus 1.18 +/- 0.20 for Kt/Vdp, compared to single-pool values of
Kt/V = 1.34 +/- 0.23. CONCLUSION: This technique may be readily programmed
into on-line urea monitors to provide current and extrapolated values of
Ceq and Kt/Vdp from about the first hour of dialysis.
相似文献
7.
8.
9.
Zhao P Qin ZL Ke JS Lu Y Liu M Pan W Zhao LJ Cao J Qi ZT 《第二军医大学学报》2005,26(10):1167-1167
SARS-CoV isa newly identified coronavirus that causes severe acute respiratory syndrome (SARS). Currently, there is no effective method available for prophylaxis and treatment of SARS-CoVinfections. In the present study, the influence of small interfering RNA (siRNA) on SARS-CoV nucleocapsid (N) protein expression was detected in cultured cells and mouse muscles. Four siRNA expression cassettes driven by mouse U6 promoter targeting SARS-CoV N gene were prepared, and their inhibitory effects on expression of N and enhanced green fluorescence protein (EGFP) fusion protein were observed. 相似文献
10.
溴莫尼定对视网膜缺血性损伤神经保护作用的实验研究 总被引:1,自引:1,他引:0
目的:探讨溴莫尼定(brimonidine)对视网膜缺血性损伤神经的保护作用。方法:新西兰大耳白兔32只,随机分为正常对照组、生理盐水治疗组、噻吗心安(timolol)治疗组、brimonidine治疗组,每组8只。后3组为损伤治疗组,通过生理盐水前房高压灌注的方法,制成视网膜缺血动物模型,在视网膜缺血前lh其结膜囊内分剐给予生理盐水、0.5%timolol眼液或0.2%brimonidine眼液局部治疗。在灌注后7d,观察图形视网膜电图(P-ERG)b波振幅变化,并进行组织形态学观察和视网膜神经节细胞(RGC)计数分析。结果:灌注后7d,3个损伤治疗组相对b波振幅恢复率为:7%、11%和64%,RGC标准丢失率为:43%、38%和12%,brimori-die治疗组视网膜组织形态结构接近正常对照组,而生理盐水治疗组和timolol治疗组视网膜内层组织结构损伤明显。结论:Brimonidine局部治疗对缺血诱导的视网膜结构和功能的损害有明显的神经保护作用。 相似文献